Abstract
While it is recognised that innovation treatment effects are heterogeneous, our understanding of how and which new ventures can achieve superior innovation treatment effects from public start-up subsidies remains limited. Using the resource-based view and insights from the innovation and entrepreneurship literatures, we develop a theoretical framework concerning the effects of founder human capital in enabling subsidised new ventures’ innovation activities to benefit from public support. Using detailed data on new ventures founded in Germany, we show that founder human capital plays an important role but that not all human capital matters equally. Specifically, founder specific human capital, and particularly founder entrepreneurship and innovation experience, equips new ventures with advantages that enable them to generate superior innovation treatment effects from start-up subsidies. The role of general human capital, on the other hand, is more mixed. These findings contribute to research on the effectiveness of start-up policy instruments by showing that differences in founder human capital offer a fundamental explanation for why treatment effects vary substantially. We discuss the implications for theory and policy.